{
    "name": "fulvestrant",
    "comment": "Rx",
    "other_names": [
        "Faslodex"
    ],
    "classes": [
        "Antineoplastics",
        "Estrogen Receptor Antagonist"
    ],
    "source": "https://reference.medscape.com/drug/faslodex-fulvestrant-342224",
    "pregnancy": {
        "common": [
            "Based on findings from animal studies and its mechanism of action, fulvestrant can cause fetal harm when administered to a pregnant woman",
            "In animal reproduction studies, administration of fulvestrant to pregnant rats and rabbits during organogenesis resulted in embryo-fetal toxicity at daily doses that are significantly less than the maximum recommended human dose",
            "Advise pregnant women of the potential risk to a fetus",
            "Advise females of reproductive potential to use effective contraception during treatment and for 1 year after the last dose",
            "Pregnancy testing is recommended for females of reproductive potential within 7 days prior to initiating fulvestrant"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Excretion in human milk unknown",
            "Detected in rat milk",
            "Because of the potential for serious adverse reactions in breastfed infants, advise lactating women not to breastfeed during treatment and for 1 year after the final dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to fulvestrant or any component of formulation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in bleeding diathesis, thrombocytopenia, therapeutic anticoagulation",
                "Systemic exposure was increased in patients with moderate hepatic impairment (see Dosage Modifications)",
                "Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception; see Pregnancy section",
                "Therapy can interfere with estradiol measurement by immunoassay, resulting in falsely elevated estradiol levels",
                "Injection site related events including sciatica, neuralgia, neuropathic pain, and peripheral neuropathy reported; caution should be taken while administering therapy at dorsogluteal injection site due to proximity of underlying sciatic nerve"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "siponimod",
            "description": {
                "common": "siponimod and fulvestrant both increase  immunosuppressive effects; risk of infection. Use Caution/Monitor. Caution if coadministered because of additive immunosuppressive effects during such therapy and in the weeks following administration. When switching from drugs with prolonged immune effects, consider the half-life and mode of action of these drugs to avoid unintended additive immunosuppressive effects."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "maitake",
            "description": {
                "common": "maitake increases effects of fulvestrant by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research)."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "taurine",
            "description": {
                "common": "fulvestrant decreases levels of taurine by unspecified interaction mechanism. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Frequency Not Defined Neutropenia Leukopenia Infections Fatigue Nausea Anemia Stomatitis Diarrhea Thrombocytopenia Vomiting Alopecia Rash Decreased appetite Pyrexia",
            "percent": "10"
        },
        {
            "name": "Neutropenia",
            "percent": "7.5"
        },
        {
            "name": "Leukopenia",
            "percent": "7.5"
        },
        {
            "name": "Infections",
            "percent": "6.7"
        },
        {
            "name": "Fatigue",
            "percent": "6.7"
        },
        {
            "name": "Nausea",
            "percent": "6.4"
        },
        {
            "name": "Anemia",
            "percent": "6.1"
        },
        {
            "name": "Stomatitis",
            "percent": "5.8"
        },
        {
            "name": "Diarrhea",
            "percent": "5.8"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "3.8"
        },
        {
            "name": "Vomiting",
            "percent": "0.9"
        },
        {
            "name": "Alopecia",
            "percent": "7.5"
        },
        {
            "name": "Rash",
            "percent": "7.5"
        },
        {
            "name": "Decreased appetite",
            "percent": "6.7"
        },
        {
            "name": "Pyrexia",
            "percent": "6.7"
        },
        {
            "name": "Asthenia",
            "percent": "6.4"
        },
        {
            "name": "Aspartate aminotransferase increased",
            "percent": "6.1"
        },
        {
            "name": "Dysgeusia",
            "percent": "5.8"
        },
        {
            "name": "Epistaxis",
            "percent": "5.8"
        },
        {
            "name": "Lacrimation increased",
            "percent": "3.8"
        },
        {
            "name": "Dry skin",
            "percent": "0.9"
        },
        {
            "name": "Alanine aminotransferase increased",
            "percent": null
        },
        {
            "name": "Vision blurred",
            "percent": null
        },
        {
            "name": "Dry eye",
            "percent": null
        },
        {
            "name": "Febrile neutropenia",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "Aspartate aminotransferase increased",
            "percent": null
        },
        {
            "name": "Dysgeusia",
            "percent": null
        },
        {
            "name": "Epistaxis",
            "percent": null
        },
        {
            "name": "Lacrimation increased",
            "percent": null
        },
        {
            "name": "Dry skin",
            "percent": null
        },
        {
            "name": "Alanine aminotransferase increased",
            "percent": null
        },
        {
            "name": "Vision blurred",
            "percent": null
        },
        {
            "name": "Dry eye",
            "percent": null
        },
        {
            "name": "Febrile neutropenia",
            "percent": null
        }
    ]
}